Chemfab Alkalis Limited (CHEMFAB) - Net Assets
Based on the latest financial reports, Chemfab Alkalis Limited (CHEMFAB) has net assets worth Rs3.79 Billion INR (≈ $40.99 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs5.67 Billion ≈ $61.36 Million USD) and total liabilities (Rs1.88 Billion ≈ $20.37 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Chemfab Alkalis Limited (CHEMFAB) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs3.79 Billion |
| % of Total Assets | 66.81% |
| Annual Growth Rate | 11.27% |
| 5-Year Change | 42.14% |
| 10-Year Change | 177.66% |
| Growth Volatility | 10.62 |
Chemfab Alkalis Limited - Net Assets Trend (2009–2025)
This chart illustrates how Chemfab Alkalis Limited's net assets have evolved over time, based on quarterly financial data. Also explore CHEMFAB total assets for the complete picture of this company's asset base.
Annual Net Assets for Chemfab Alkalis Limited (2009–2025)
The table below shows the annual net assets of Chemfab Alkalis Limited from 2009 to 2025. For live valuation and market cap data, see Chemfab Alkalis Limited stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs3.80 Billion ≈ $41.09 Million |
-1.88% |
| 2024-03-31 | Rs3.87 Billion ≈ $41.88 Million |
+7.17% |
| 2023-03-31 | Rs3.61 Billion ≈ $39.08 Million |
+21.26% |
| 2022-03-31 | Rs2.98 Billion ≈ $32.23 Million |
+11.48% |
| 2021-03-31 | Rs2.67 Billion ≈ $28.91 Million |
-2.98% |
| 2020-03-31 | Rs2.76 Billion ≈ $29.80 Million |
+9.72% |
| 2019-03-31 | Rs2.51 Billion ≈ $27.16 Million |
+6.32% |
| 2018-03-31 | Rs2.36 Billion ≈ $25.54 Million |
+43.35% |
| 2017-03-31 | Rs1.65 Billion ≈ $17.82 Million |
+20.39% |
| 2016-03-31 | Rs1.37 Billion ≈ $14.80 Million |
+5.62% |
| 2015-03-31 | Rs1.30 Billion ≈ $14.01 Million |
+6.98% |
| 2014-03-31 | Rs1.21 Billion ≈ $13.10 Million |
+14.25% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.46 Million |
+20.66% |
| 2012-03-31 | Rs878.58 Million ≈ $9.50 Million |
+9.30% |
| 2011-03-31 | Rs803.84 Million ≈ $8.69 Million |
+9.54% |
| 2010-03-31 | Rs733.83 Million ≈ $7.94 Million |
+6.58% |
| 2009-03-31 | Rs688.51 Million ≈ $7.45 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Chemfab Alkalis Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 93.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs31.92 Million | 0.84% |
| Common Stock | Rs143.64 Million | 3.78% |
| Other Comprehensive Income | Rs101.32 Million | 2.67% |
| Other Components | Rs3.52 Billion | 92.71% |
| Total Equity | Rs3.80 Billion | 100.00% |
Chemfab Alkalis Limited Competitors by Market Cap
The table below lists competitors of Chemfab Alkalis Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ilji Technology Co. Ltd
KQ:019540
|
$63.54 Million |
|
OnMobile Global Limited
NSE:ONMOBILE
|
$63.55 Million |
|
Thermaltake Technology Co Ltd
TWO:3540
|
$63.58 Million |
|
Cellid Co. Ltd
KQ:299660
|
$63.58 Million |
|
Immutep Ltd
AU:IMM
|
$63.53 Million |
|
Fortune Minerals Limited
TO:FT
|
$63.47 Million |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
$63.46 Million |
|
CTCBIO Inc
KQ:060590
|
$63.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chemfab Alkalis Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,872,648,000 to 3,799,881,000, a change of -72,767,000 (-1.9%).
- Net loss of 69,403,000 reduced equity.
- Dividend payments of 17,319,000 reduced retained earnings.
- Share repurchases of 10,410,000 reduced equity.
- New share issuances of 10,410,000 increased equity.
- Other comprehensive income decreased equity by 14,454,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs-69.40 Million | -1.83% |
| Dividends Paid | Rs17.32 Million | -0.46% |
| Share Repurchases | Rs10.41 Million | -0.27% |
| Share Issuances | Rs10.41 Million | +0.27% |
| Other Comprehensive Income | Rs-14.45 Million | -0.38% |
| Other Changes | Rs28.41 Million | +0.75% |
| Total Change | Rs- | -1.88% |
Book Value vs Market Value Analysis
This analysis compares Chemfab Alkalis Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.54x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.44x to 1.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-03-31 | Rs75.07 | Rs408.70 | x |
| 2010-03-31 | Rs80.01 | Rs408.70 | x |
| 2011-03-31 | Rs87.64 | Rs408.70 | x |
| 2012-03-31 | Rs95.79 | Rs408.70 | x |
| 2013-03-31 | Rs115.58 | Rs408.70 | x |
| 2014-03-31 | Rs132.06 | Rs408.70 | x |
| 2015-03-31 | Rs141.27 | Rs408.70 | x |
| 2016-03-31 | Rs148.89 | Rs408.70 | x |
| 2017-03-31 | Rs179.64 | Rs408.70 | x |
| 2018-03-31 | Rs168.34 | Rs408.70 | x |
| 2019-03-31 | Rs179.27 | Rs408.70 | x |
| 2020-03-31 | Rs196.67 | Rs408.70 | x |
| 2021-03-31 | Rs189.54 | Rs408.70 | x |
| 2022-03-31 | Rs209.41 | Rs408.70 | x |
| 2023-03-31 | Rs252.59 | Rs408.70 | x |
| 2024-03-31 | Rs269.87 | Rs408.70 | x |
| 2025-03-31 | Rs266.10 | Rs408.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chemfab Alkalis Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.83%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.08%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.37x
- Recent ROE (-1.83%) is below the historical average (9.25%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 11.39% | 8.72% | 0.83x | 1.57x | Rs9.55 Million |
| 2010 | 9.83% | 8.27% | 0.83x | 1.44x | Rs-1.23 Million |
| 2011 | 12.04% | 12.09% | 0.78x | 1.28x | Rs16.36 Million |
| 2012 | 8.51% | 9.77% | 0.68x | 1.27x | Rs-13.12 Million |
| 2013 | 22.15% | 20.26% | 0.85x | 1.28x | Rs128.81 Million |
| 2014 | 13.58% | 14.60% | 0.62x | 1.49x | Rs43.36 Million |
| 2015 | 7.89% | 9.26% | 0.59x | 1.44x | Rs-27.30 Million |
| 2016 | 6.33% | 8.55% | 0.54x | 1.36x | Rs-50.25 Million |
| 2017 | 9.39% | 11.02% | 0.65x | 1.31x | Rs-10.01 Million |
| 2018 | 10.79% | 13.84% | 0.62x | 1.26x | Rs18.57 Million |
| 2019 | 6.67% | 8.68% | 0.60x | 1.28x | Rs-83.55 Million |
| 2020 | 9.24% | 12.46% | 0.59x | 1.26x | Rs-21.06 Million |
| 2021 | -3.04% | -4.50% | 0.54x | 1.25x | Rs-348.64 Million |
| 2022 | 9.65% | 10.60% | 0.77x | 1.18x | Rs-10.53 Million |
| 2023 | 17.87% | 19.50% | 0.80x | 1.14x | Rs284.48 Million |
| 2024 | 6.80% | 8.04% | 0.65x | 1.29x | Rs-124.03 Million |
| 2025 | -1.83% | -2.08% | 0.64x | 1.37x | Rs-449.39 Million |
Industry Comparison
This section compares Chemfab Alkalis Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $8,083,043,484
- Average return on equity (ROE) among peers: 14.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chemfab Alkalis Limited (CHEMFAB) | Rs3.79 Billion | 11.39% | 0.50x | $63.53 Million |
| Aarti Industries Limited (AARTIIND) | $49.21 Billion | 11.08% | 0.74x | $1.99 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.11 Billion | 1.88% | 1.36x | $37.34 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $1.66 Billion | 30.02% | 1.39x | $420.87 Million |
| Aether Industries Limited (AETHER) | $12.45 Billion | 10.48% | 0.11x | $1.68 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $11.05 Billion | 19.80% | 1.09x | $1.45 Billion |
| Alkali Metals Limited (ALKALI) | $658.97 Million | 9.93% | 0.56x | $7.38 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $1.16 Billion | 20.83% | 1.93x | $838.56 Million |
| Ami Organics Limited (AMIORG) | $822.19 Million | 28.33% | 1.59x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $1.65 Billion |
About Chemfab Alkalis Limited
Chemfab Alkalis Limited, together with its subsidiary, Chemfab Alkalis Karaikal Limited, manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments. The company offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor produ… Read more